Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.07 CAD | +7.69% |
|
+7.69% | +180.00% |
06-05 | NAVCO Pharmaceuticals Inc. Readies Launch of Antimicrobial Line | CI |
05-31 | NAVCO Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024 | CI |
- Stock Market
- Equities
- NAV Stock
- News NAVCO Pharmaceuticals Inc.